Astellas Pharma Global Development, Inc.

This study tested a drug called enfortumab vedotin for people with non-muscle invasive bladder cancer that didn't respond to standard BCG therapy. The drug was delivered directly into the bladder through a thin tube. The study aimed to find the right dose and see if it could help…

This early-stage study is testing a new drug called ASP2074 in adults with advanced solid tumors that have spread and who have run out of standard treatment options. The main goals are to find a safe dose for future research and to understand what side effects the drug might caus…

This study tested a drug called gilteritinib combined with standard chemotherapy in children and young adults with a specific, hard-to-treat form of acute myeloid leukemia (AML) that had come back or not responded to prior treatment. The goal was to find a safe and effective dose…

This was the first study to test a new oral drug called ASP5502 in people. The main goal was to check its safety and how the body processes it. It involved healthy adults and people with primary Sjögren's syndrome, an autoimmune disease that causes severe dryness and fatigue. The…

This was the first-ever study in people of a new type of CAR-T cell therapy called ASP2802 for B-cell lymphoma that has come back or not responded to prior treatments. The main goal was to find a safe dose and understand how the body handles the treatment. The study was terminate…

This was the first study in people to test a new cancer treatment called ASP1012, which is a virus modified in a lab to specifically infect and destroy cancer cells. The main goals were to find a safe dose and check for side effects in adults whose cancer had spread and who had r…